Search

everythinglearnresearchcommunity

for

Search:↓

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

In vivo lineage labelling is better than in vitro methods for identifying and understanding stem cells.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

New therapies are being developed that target integrin pathways to treat various diseases.

The nervous system helps control stem cell behavior and immune responses, affecting tissue repair and maintenance.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

A new gene, JMJD1C, may affect testosterone levels in men.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

Hair loss linked to heart disease in young men.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Finasteride can treat prostatic haematuria, but its use is controversial.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Hair loss can cause emotional and social issues, and various treatments, including medication, surgery, and psychological support, are needed.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Urologists should screen for mental health issues before and during finasteride treatment.

Finasteride in male rats causes liver and metabolic issues in their offspring.